The DIPCOVAN kit can detect both spikes as well as nucleocapsid (S&N) proteins of the SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent
The Defence Research and Development Organisation (DRDO) has developed an antibody detection kit known as Dipcovan, which is expected to be available at Rs 75 per test in the market from June first week onwards.The kit has been developed by the .
After 2-DG drug, DRDO develops Covid antibody detection kit
DRDO said three batches of the product were validated for the last one year. The antibody detection kit was approved by the Indian Council of Medical Research (ICMR) in April 2021.
Share Via Email
| A+A A-
The kit is believed to be very useful for understanding COVID-19 epidemiology and assessing an individual s previous SARS-CoV-2 exposure. (Photo | @DRDO India) By Express News Service
NEW DELHI: The Defence Research and Development Organisation (DRDO) has developed an antibody test kit for the early screening of COVID.
DIPCOVAN, the DIPAS-VDx COVID 19 IgG Antibody Microwell ELISA for sero-surveillance has been developed by the Defence Institute of Physiology and Allied Sciences (DIPAS) in association with Delhi-based firm Vanguard Diagnostics Pvt Ltd.
Coronavirus | DRDO develops antibody detection kit
Updated:
Updated:
Commercial launch of product in June first week
Share Article
Commercial launch of product in June first week
The Defence Research and Development Organisation (DRDO) on Friday said it had, in collaboration with a company, developed an antibody detection kit for spotting SARS-CoV-2 virus with a high sensitivity of 97% and specificity of 99%.
“The DIPCOVAN kit was developed indigenously by the scientists, followed by extensive validation on more than 1,000 patient samples at various COVID designated hospitals in Delhi. Three batches of the product were validated during last one year. The antibody detection kit is approved by Indian Council of Medical Research (ICMR) in April 2021,” it said in a statement.
DRDO Scientists Develop Indigenous COVID Antibody Detection Kit DIPCOVAN , To Be Launched Early Next Month
Covid-19 antibody detection kit DIPCOVAN (PIB)
Defence Institute of Physiology and Allied Sciences (DIPAS), a laboratory of Defence Research and Development Organisation (DRDO), has developed an antibody detection-based kit DIPCOVAN .
The DIPCOVAN kit can detect both spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent. The kit has been developed in association with Vanguard Diagnostics Pvt Ltd, a development and manufacturing diagnostics company based at New Delhi.
The DIPCOVAN kit was developed indigenously by the scientists, followed by extensive validation on more than 1,000 patient samples at various Covid designated hospitals in Delhi.